Volkswagen is one of the world's largest automotive manufacturers. Automotive brands include Volkswagen passenger cars, Audi, Bentley, Bugatti, Lamborghini, Porsche, SEAT, and Skoda. Commercial vehicle brands include MAN, Scania, and Volkswagen. The company's financial services group provides dealer financing to support floor plans, consumer financing for vehicle purchases, and other financial services.

VOLKSWAGEN AG PFD UNS/ADR by Volkswagen AG

Volkswagen

Advent Technologies Reports Share Purchase Deal With FER Fischer Edelstahlrohre For Purchase Of SerEnergy, FES, The Fuel Cell Systems Business Of fischer group For €52M

- Special meeting of stockholders to be held at 10:00 a.m. Eastern Time on July 22, 2021 via live webcast 
- The anticipated closing date for the business combination is July 23, 2021 
- The post-combination company will be renamed Lucid Group, Inc. and its common stock is expected to trade on Nasdaq under the ticker symbol &quot;LCID&quot;
NEW YORK, June 25, 2021 /PRNewswire/ -- Churchill Capital Corp IV (&quot;Churchill IV&quot; or &quot;CCIV&quot;) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCIV#NYSE">CCIV</a>), a special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the &quot;SEC&quot;)&nbsp;has declared effective Churchill IV&#39;s registration statement on Form S-4 (as amended to the date hereof, the &quot;Registration Statement&quot;). The Registration Statement includes a proxy statement/prospectus for the special meeting of the stockholders of Churchill IV in connection with its proposed combination with Lucid Motors, a leader in EV technology which is setting new standards for sustainable mobility with its advanced luxury EVs.
<a href="https://mma.prnewswire.com/media/1442290/Churchill_Capital_Corp_IV_Logo.html" target="_blank"><img alt="(PRNewsfoto/Churchill Capital Corp IV)" src="https://mma.prnewswire.com/media/1442290/Churchill_Capital_Corp_IV_Logo.jpg" /> </a>
Churchill IV has scheduled the special meeting of stockholders at 10:00 a.m. Eastern Time on July 22, 2021 via live webcast. The proxy statement/prospectus is available in the Investor Resources section of <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3208846-1&amp;h=1889003187&amp;u=https%3A%2F%2Fiv.churchillcapitalcorp.com%2F&amp;a=Churchill+IV" target="_blank">Churchill IV</a>&#39;s&nbsp;website as well as on <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3208846-1&amp;h=3885467041&amp;u=http%3A%2F%2Fwww.sec.gov%2F&amp;a=www.sec.gov" target="_blank">www.sec.gov</a>.
The effectiveness of the Registration Statement is another important milestone in the completion of the transaction, which is currently expected to occur on July 23, 2021, the day immediately following the special meeting of stockholders, subject to final stockholder approval and satisfaction of other customary conditions.
&quot;Lucid has exceeded our expectations since announcing the merger at the end of February and is set to become a leading US technology and sustainable mobility company. We believe Lucid will take EVs to the next level with its proprietary technology and will provide attractive opportunities for Churchill investors,&quot; said Michael Klein, Chairman and CEO of Churchill IV. &quot;CEO Peter Rawlinson continues to extend Lucid&#39;s technology, expand production capacity and attract leading talent. The Lucid Air Dream Edition is fully reserved, and the company has concluded its preproduction program and is on track for expected production and deliveries in the second half of 2021. We have great confidence in Lucid&#39;s leadership and best-in-class board which includes representation from Churchill Capital.&quot;&nbsp;
Holders of Churchill IV&#39;s common stock as of the close of business on June 21, 2021 are entitled to vote at the special meeting. The Churchill IV Board of Directors unanimously recommends that stockholders vote &quot;FOR&quot; the business combination proposal with Lucid as well as the other proposals set forth in the definitive proxy statement/prospectus.
Churchill IV, whose shares of common stock, warrants and units are currently listed on the New York Stock Exchange (the &quot;NYSE&quot;), also announced that, in connection with the closing of the business combination, it intends to delist from the NYSE and list the shares of common stock and warrants of the post-combination company, to be renamed Lucid Group, Inc., on The Nasdaq Stock Market LLC (&quot;Nasdaq&quot;) under the ticker symbols &quot;LCID&quot; and &quot;LCID.WS&quot;, respectively. The Nasdaq listing and NYSE delisting are subject to the closing of the business combination and fulfillment of all Nasdaq listing requirements.
Lucid&#39;s proposed public company board of directors, which is expected to be effective as of the closing of the transaction and which is expected to be majority independent, comprises&nbsp;nine diverse directors with deep automotive, technology and industrial expertise:
<ul>
<li>Andrew Liveris, Chairman of the Board &ndash; Former Chairman and CEO of The Dow Chemical Company</li>
<li>Peter Rawlinson, Executive Director &ndash; Lucid Chief Executive Officer and Chief Technology Officer</li>
<li>Turqi Alnowaiser, Non-Executive Director&nbsp;&ndash;&nbsp;Deputy Governor and Head of the International Investments Division at the Public Investment Fund of the Kingdom of Saudi Arabia</li>
<li>Glenn R. August, Non-Executive Director &ndash; Founder, Senior Partner and Chief Executive Officer of Oak Hill Advisors</li>
<li>Nancy Gioia, Non-Executive Director &ndash;&nbsp;Former Director of Global Connectivity, Electrical and User Experience, Ford Motor Company</li>
<li>Frank Lindenberg, Non-Executive Director&nbsp;&ndash; Former Chief Financial Officer of Mercedes-Benz Cars</li>
<li>Nichelle Maynard-Elliott, Non-Executive Director&nbsp;&ndash; Former Executive Director, M&amp;A, for Praxair, Inc.</li>
<li>Tony Posawatz, Non-Executive Director &ndash;&nbsp;President and Chief Executive Officer of Invictus iCAR LLC</li>
<li>Janet S. Wong, Non-Executive Director &ndash; Partner (Retired) at KPMG LLP</li>
</ul>

News

CCIV

Churchill Capital Corp. IV Reports SEC Declared Effective Co.'s Registration Statement Related To Proxy Statement For Special Meeting In Connection With Proposed Combination With Lucid Motors; Meeting Scheduled For Jul. 22, 2021 At 10 a.m. EDT

Pivotal Research analyst Mitch Kummetz maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Buy and raises the price target from $167 to $175.

Price Target

Analyst Ratings

Pivotal Research Maintains Buy on Nike, Raises Price Target to $175

HC Wainwright &amp; Co. analyst Kevin Dede initiates coverage on Neptune Digital Assets (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/NDA#TSXV">NDA</a>) with a Buy rating and announces Price Target of C$1.

Initiation

TSXV:NDA

HC Wainwright & Co. Initiates Coverage On Neptune Digital Assets with Buy Rating, Announces Price Target of C$1

HC Wainwright &amp; Co. analyst Vernon Bernardino maintains Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) with a Buy and raises the price target from $5 to $9.

AEMD

HC Wainwright & Co. Maintains Buy on Aethlon Medical, Raises Price Target to $9

Pre-open movers
U.S. stock futures traded higher in early pre-market trade. The Dow Jones surged more than 300 points, while the S&amp;P 500 closed at a record high in the previous session after President Joe Biden reported a deal on infrastructure spending. Investors are awaiting earnings results from CarMax, Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmx#NYSE">KMX</a>) and Paychex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/payx#NASDAQ">PAYX</a>)
Data on personal income and outlays for May will be released at 8:30 a.m. ET, while the University of Michigan&#39;s consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. Cleveland Fed President Loretta Mester is set to speak at 11:35 a.m. ET, while Federal Reserve Bank of Boston President Eric Rosengren will speak at 1:00 p.m. ET. Federal Reserve Bank of New York President John Williams is set to speak at 3:00 p.m. ET.
Futures for the Dow Jones Industrial Average jumped 85 points to 34,167.00 while the Standard &amp; Poor&rsquo;s 500 index futures rose 3 points at 4,259.00. Futures for the Nasdaq 100 index rose 18 points to 14,372.25.
The U.S. has the highest number of COVID-19 cases and deaths in the world, with total infections in the country exceeding 33,590,540 with around 603,170 deaths. India reported a total of at least 30,134,440 confirmed cases, while Brazil confirmed over 18,243,480 cases.
<a href="https://www.benzinga.com/investing/global-oil-storage-trends/">Oil prices </a>traded higher as Brent crude futures rose 0.1% to trade at $74.87 per barrel, while US WTI crude futures rose 0.1% to trade at $73.35 a barrel. US natural-gas supplies climbed 55 billion cubic feet last week, the Energy Information Administration said Thursday. The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
A Peek Into Global Markets

European markets were mostly lower today. The Spanish Ibex Index fell 0.3% and STOXX Europe 600 Index slipped 0.1%. The French CAC 40 Index fell 0.2%, London&rsquo;s FTSE 100 rose 0.1% while German DAX 30 fell 0.2%. Spain&#39;s producer price inflation increased to 15.3% year-over-year in May from a revised 13% in April. German GfK consumer climate indicator rose to -0.3 heading into July. The UK&rsquo;s GfK consumer confidence stood at -9 for June. The consumer confidence indicator in Italy surged 4.5 points to a reading of 115.1 in June, while manufacturing confidence index increased to 114.8 from 110.9. Loans to households in the Eurozone increased 3.9% in May.
Asian markets traded higher today. Japan&rsquo;s Nikkei 225 rose 0.66%, while Hong Kong&rsquo;s Hang Seng Index climbed 1.4% and China&rsquo;s Shanghai Composite Index gained 1.15%. Australia&rsquo;s S&amp;P/ASX 200 rose 0.5% and India&rsquo;s BSE Sensex gained 0.4%.

Broker Recommendation
Goldman Sachs upgraded Nokia Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nok#NYSE">NOK</a>) from Neutral to Buy.
Nokia shares rose 2.7% to $5.28 in pre-market trading.
<a href="https://www.benzinga.com/analyst-ratings/">Check out other major ratings here </a>
&nbsp;
Breaking News 
<ul>
<li>Nike Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nke#NYSE">NKE</a>) reported upbeat results for its fourth quarter and issued strong sales forecast for its fiscal full year.</li>
<li>FedEx Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdx#NYSE">FDX</a>) reported better-than-expected results for its fourth quarter.</li>
<li>Mirati Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrtx#NASDAQ">MRTX</a>) disclosed that it has received Breakthrough Therapy Designation from the FDA for patients with advanced non-small cell lung cancer harboring the KRAS G12C mutation.</li>
<li>BlackBerry Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) reported a narrower net loss for its first quarter, while sales exceeded expectations.</li>
</ul>
<a href="https://www.benzinga.com/news/">Check out other breaking news here</a>

Earnings

Eurozone

Futures

Global

Pre-Market Outlook

Markets

MRTX

PAYX

A Peek Into The Markets: US Stock Futures Up Following Thursday's Rally; Nike Posts Upbeat Results

<ul>
<li>High Tide adds another top e-commerce platform to its portfolio which will now include 3 out of the top 5 most popular e-commerce platforms for consumption accessories globally totaling 91 million site visits in 2020, including 23 million associated with Daily High Club alone.1</li>
<li>High Tide gains access to Daily High Club&#39;s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. federal legalization.</li>
<li>High Tide bolsters its online presence, by gaining access to Daily High Club&#39;s almost 800,000 followers on Instagram and over 75,000 followers on TikTok.</li>
<li>With over one million accessories sold under the Daily High Club name, High Tide adds a company to its portfolio with proven brand equity.</li>
<li>Transaction is immediately accretive as Daily High Club generated US$9.4 million in net revenue and US$1.2 million in EBITDA during the 12 months ended April 2021.</li>
<li>Pro forma for the acquisition, High Tide&#39;s revenue run rate in the U.S. exceeds CAD$50 million.</li>
</ul>
CALGARY, AB, June 25, 2021 /PRNewswire/ - High Tide Inc. (&quot;High Tide&quot; or the &quot;Company&quot;) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HITI#TSXV">HITI</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that it is taking another step towards solidifying itself as the leader within the U.S. e-commerce marketplace for consumption accessories by entering into a definitive agreement (the &quot;Acquisition Agreement&quot;) pursuant to which High Tide USA Inc., a wholly-owned U.S. subsidiary of the Company, will acquire 100% of the issued and outstanding shares of DHC Supply LLC (the &quot;Transaction&quot;) operating as Daily High Club (&quot;Daily High Club&quot;).
<a href="https://mma.prnewswire.com/media/1551413/High_Tide_Inc__High_Tide_Continues_to_Expand_U_S__E_Commerce_Pre.html" target="_blank"><img alt="High Tide Inc. - June 25, 2021 (CNW Group/High Tide Inc.)" src="https://mma.prnewswire.com/media/1551413/High_Tide_Inc__High_Tide_Continues_to_Expand_U_S__E_Commerce_Pre.jpg" /> </a>
&quot;In alignment with our intention to become a dominant player in the U.S. e-commerce marketplace through a combination of organic growth and accretive acquisitions, specifically targeting businesses with strong brand loyalty, I am thrilled to announce the acquisition of Daily High Club,&quot; said Raj Grover, President and Chief Executive Officer of High Tide. &quot;Daily High Club stood out to us because it is an increasingly popular consumption accessories online retailer, with a rapidly growing subscription box model which can easily be tailored to include cannabis products in the event of U.S. federal legalization. This subscription box model is complementary to our existing accessories e-commerce portfolio, and as such creates numerous opportunities for potential synergies. It&#39;s my pleasure to welcome Harrison and the DHC team into our High Tide family,&quot; added Mr. Grover.
&quot;I am extremely excited to be joining the High Tide team and see a huge opportunity to boost High Tide&#39;s brands the same way we built our loyal following for Daily High Club,&quot; said Harrison Baum, Founder and Chief Executive Officer of Daily High Club. &quot;Daily High Club&#39;s social media dominance, coupled with High Tide&#39;s vast manufacturing capabilities and mature e-commerce platforms should yield meaningful synergies. I could not be more thrilled to be part of the High Tide family,&quot; added Mr. Baum.
<table border="0" cellpadding="0" cellspacing="0">
<tbody>
<tr>
<td>
_______________
</td>
</tr>
<tr>
<td>
1&nbsp;As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. related to Grasscity, SmokeCartel and Daily High Club. Traffic data provided by Google Analytics.
</td>
</tr>
</tbody>
</table>
Strategic Highlights
With over 10 years of experience in the cannabis accessory sector, including through our subsidiaries Grasscity and Smoke Cartel, High Tide is constantly exploring opportunities to further increase its share in the growing consumption accessories market. Daily High Club&#39;s consumption accessories subscription box model, with over 15,000 and growing active monthly subscribers, allows the Company to ensure this Transaction will be immediately accretive through cross-selling opportunities, and offering subscription box memberships across its other e-commerce platforms, including Grasscity.com and Smokecartel.com. Although currently operating in the hemp-derived CBD and consumption accessory space, High Tide intends to expand its cannabis retail network into the U.S. in the event of federal legalization, through cannabis subscription boxes, mature e-commerce sites and bricks and mortar locations.
Transaction Details
The Transaction, which is an arm&#39;s length transaction, is subject to, among other things, receipt of required TSX Venture Exchange (&quot;TSXV&quot;) approval, and other customary conditions of closing, is expected to close around the end of June 2021. Pursuant to the terms of the Transaction, High Tide USA Inc. (&quot;Subco&quot;), a Nevada corporation and a wholly-owned subsidiary of High Tide, will acquire 100% of the issued and outstanding shares of Daily High Club.
Total consideration to Daily High Club shareholders will be US$10 million and Daily High Club is expected to have approximately US$0.8 million of cash on closing. The consideration will be comprised of: (i) US$6.75 Million (the &quot;Share Consideration&quot;) in common shares of High Tide (&quot;High Tide Shares&quot;) on the basis of a deemed price per High Tide&nbsp;Share equal to the volume weighted average price per High Tide Share on Nasdaq for the 10 consecutive trading days preceding the closing of the Transaction (&quot;Closing&quot;); and (ii) US$3.25 million in cash (collectively with the Share Consideration, the &quot;Consideration&quot;).&nbsp;
In connection with the Transaction, High Tide is excited to announce that Harrison Baum will be joining the High Tide team on Closing as Director of Digital Marketing to oversee all social media initiatives for High Tide globally.
The Transaction has been unanimously approved by the board of directors/managers of each of High Tide and Daily High Club. The High Tide&nbsp;Shares issued pursuant to the Share Consideration are subject to a statutory hold period of four months and one day.&nbsp; In addition, shares having a value of 25% will be held in escrow to insure certain indemnification obligations if claims arise.

HITI

TSXV:HITI

High Tide Reports Purchase Of Daily High Club For $10M In Cash, Stock

NVAX

Serum Institute of India Says Started Making First Batch of Novavax Covid-19 Vaccine

New Street Research initiates coverage on Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) with a Buy rating and announces Price Target of $325.

New Street Research Initiates Coverage On Sea with Buy Rating, Announces Price Target of $325

JP Morgan analyst Arun Jayaram upgrades Continental Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLR#NYSE">CLR</a>) from Neutral to Overweight and announces $46 price target.

Upgrades

JP Morgan Upgrades Continental Resources to Overweight, Announces $46 Price Target

Regeneron Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/regn#NASDAQ">REGN</a>) and Sanofi (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sny#NYSE">SNY</a>) today announced that the European Commission (EC) has approved the PD-1 inhibitor Libtayo&#174; (cemiplimab) to treat adults with locally advanced or metastatic basal cell carcinoma (BCC) who have progressed on or are intolerant to a hedgehog pathway inhibitor (HHI). 
BCC is the most common type of skin cancer worldwide, representing up to 80% of non-melanoma skin cancers, and incidence is increasing across many European countries. While the large majority of BCCs are caught early and easily cured with surgery and/or radiation, a small proportion of cases can develop into advanced BCC and penetrate deeper into surrounding tissues (locally advanced) or spread to other parts of the body (metastatic), becoming more difficult to treat. 
"Libtayo is the first immunotherapy to show a clinical benefit in patients with advanced BCC after HHI therapy in a pivotal trial, and with this first-in-class approval has the potential to transform treatment for patients in Europe whose cancer has progressed despite HHI treatment," said Israel Lowy, M.D., Ph.D., Senior Vice President, Translational and Clinical Sciences, Oncology at Regeneron. "We look forward to continuing to investigate this medicine in additional settings, with the goal of helping more patients with difficult-to-treat cancers around the world."
Libtayo is now approved for three advanced cancers in the European Union, following the EC's concurrent approval of Libtayo for the first-line treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumor cells have ≥50% PD-L1 expression and no EGFR, ALK or ROS1 aberrations. In 2019, Libtayo was approved by the EC as the first treatment for adults with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not candidates for curative surgery or curative radiation. Across all of its approved indications, Libtayo had a generally consistent safety profile. Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue during or after treatment with Libtayo.
The EC approval in BCC is based on data from the largest prospective clinical trial (n=119) in patients with advanced BCC previously treated with an HHI to date. Libtayo-treated patients with locally advanced BCC experienced an objective response rate (ORR) of 32% (95% confidence interval [CI]: 22-43) (25% partial response, 7% complete response) by independent central review. Libtayo-treated patients with metastatic BCC demonstrated an ORR of 29% (95% CI: 15-46) (26% partial response, 3% complete response) by investigator assessment. In addition, approximately 90% of patients across both groups had a duration of response (DOR) of 6 months or longer per Kaplan Meier estimates, and the median DOR has not been reached for either group. Median duration of follow-up was 16 months for locally advanced BCC and 9 months for metastatic BCC.
Safety was assessed in 816 patients across all four Libtayo monotherapy pivotal trials in its approved indications. Adverse events were serious in 30% of patients and led to permanent discontinuation in 8% of patients. Immune–related adverse reactions occurred in 22% of patients and led to permanent discontinuation in 4% of patients. The most common immune-related adverse reactions were hypothyroidism (8%), hyperthyroidism (3%), pneumonitis (3%), hepatitis (2%), colitis (2%) and immune-related skin adverse reactions (2%). 
"Since its launch in Europe just two years ago, Libtayo has redefined the standard of care for advanced CSCC and has the potential to do the same in advanced BCC," said Peter C. Adamson, M.D., Global Development Head, Oncology at Sanofi. "Together with Regeneron, we're committed to addressing gaps in the treatment of advanced forms of non-melanoma skin cancer." 
Regeneron Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/regn#NASDAQ">REGN</a>) and Sanofi today announced that the European Commission (EC) has approved the PD-1 inhibitor Libtayo&#174; (cemiplimab) to treat adults with locally advanced or metastatic basal cell carcinoma (BCC) who have progressed on or are intolerant to a hedgehog pathway inhibitor (HHI). 
BCC is the most common type of skin cancer worldwide, representing up to 80% of non-melanoma skin cancers, and incidence is increasing across many European countries. While the large majority of BCCs are caught early and easily cured with surgery and/or radiation, a small proportion of cases can develop into advanced BCC and penetrate deeper into surrounding tissues (locally advanced) or spread to other parts of the body (metastatic), becoming more difficult to treat. 
"Libtayo is the first immunotherapy to show a clinical benefit in patients with advanced BCC after HHI therapy in a pivotal trial, and with this first-in-class approval has the potential to transform treatment for patients in Europe whose cancer has progressed despite HHI treatment," said Israel Lowy, M.D., Ph.D., Senior Vice President, Translational and Clinical Sciences, Oncology at Regeneron. "We look forward to continuing to investigate this medicine in additional settings, with the goal of helping more patients with difficult-to-treat cancers around the world."
Libtayo is now approved for three advanced cancers in the European Union, following the EC's concurrent approval of Libtayo for the first-line treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumor cells have ≥50% PD-L1 expression and no EGFR, ALK or ROS1 aberrations. In 2019, Libtayo was approved by the EC as the first treatment for adults with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not candidates for curative surgery or curative radiation. Across all of its approved indications, Libtayo had a generally consistent safety profile. Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue during or after treatment with Libtayo.
The EC approval in BCC is based on data from the largest prospective clinical trial (n=119) in patients with advanced BCC previously treated with an HHI to date. Libtayo-treated patients with locally advanced BCC experienced an objective response rate (ORR) of 32% (95% confidence interval [CI]: 22-43) (25% partial response, 7% complete response) by independent central review. Libtayo-treated patients with metastatic BCC demonstrated an ORR of 29% (95% CI: 15-46) (26% partial response, 3% complete response) by investigator assessment. In addition, approximately 90% of patients across both groups had a duration of response (DOR) of 6 months or longer per Kaplan Meier estimates, and the median DOR has not been reached for either group. Median duration of follow-up was 16 months for locally advanced BCC and 9 months for metastatic BCC.
Safety was assessed in 816 patients across all four Libtayo monotherapy pivotal trials in its approved indications. Adverse events were serious in 30% of patients and led to permanent discontinuation in 8% of patients. Immune–related adverse reactions occurred in 22% of patients and led to permanent discontinuation in 4% of patients. The most common immune-related adverse reactions were hypothyroidism (8%), hyperthyroidism (3%), pneumonitis (3%), hepatitis (2%), colitis (2%) and immune-related skin adverse reactions (2%). 
"Since its launch in Europe just two years ago, Libtayo has redefined the standard of care for advanced CSCC and has the potential to do the same in advanced BCC," said Peter C. Adamson, M.D., Global Development Head, Oncology at Sanofi. "Together with Regeneron, we're committed to addressing gaps in the treatment of advanced forms of non-melanoma skin cancer."

REGN

Regeneron Pharmaceuticals and Sanofi Announced Libtayo Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

AbbVie (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abbv#NYSE">ABBV</a>) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of RINVOQ&#174; (upadacitinib), an oral, selective and reversible JAK inhibitor, for the expanded use in adults (15 mg or 30 mg, once daily) and adolescents 12 years and older (15 mg, once daily) with moderate to severe atopic dermatitis who are candidates for systemic therapy. RINVOQ is being studied in several immune-mediated inflammatory diseases.4-10 
The CHMP positive opinion was supported by data from the global Phase 3 program evaluating more than 2,500 patients with moderate to severe atopic dermatitis across three global pivotal studies: Measure Up 1, Measure Up 2 and AD Up.1,2 Across the three studies, both doses of RINVOQ met all primary and secondary endpoints, demonstrating rapid and significant improvement in skin clearance and reduction in itch compared to placebo at week 16 and other time points (p&lt;0.001) in patients with moderate to severe atopic dermatitis.1,2 The most commonly reported adverse events in patients treated with RINVOQ were acne, nasopharyngitis and upper respiratory tract infections.1,2 
"This milestone is an important step forward in our journey to improve care for people living with atopic dermatitis," said Michael Severino, M.D., vice chairman and president, AbbVie. "Despite available treatments, many people with moderate to severe forms of this disease continue to experience a relentless and burdensome cycle of skin and itch symptoms. We are encouraged that the CHMP has recognized RINVOQ's potential as an additional treatment option for these patients."
The CHMP positive opinion is a scientific recommendation for marketing authorization to the European Commission, which authorizes marketing approval in the European Union. The Marketing Authorization will be valid in all member states of the European Union, as well as Iceland, Liechtenstein, Norway and Northern Ireland. If approved, this will be the fourth indication for RINVOQ, and RINVOQ will be the first JAK inhibitor in the European Union to treat moderate to severe atopic dermatitis in both adults and adolescents 12 years and older.3

ABBV

AbbVie Announced EMA's CHMP Recommended Approval of RINVOQ for the Treatment of Atopic Dermatitis

Renault Group and STMicroelectronics (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stm#NYSE">STM</a>) today announced a strategic cooperation on the design, development, manufacturing, and supply to Renault Group of STMicroelectronics' products and related packaging solutions for the power electronics systems of battery-operated and hybrid vehicles. These technologies will have significant impacts on electric vehicles' driving range and charging by reducing power losses and improving efficiency, which will result in lower battery costs, more kilometres per charge, shorter charging time and reduced user-cost.
Renault Group and STMicroelectronics will work together with the objective of improving the power performance of Renault's Group's applications for electric and hybrid vehicles, based on STMicroelectronics' wide bandgap semiconductor technologies and products. The companies will collaborate on the development of efficient, rightsized, and modular components based on the understanding of Renault Group's technology needs for Silicon Carbide (SiC) devices, Gallium Nitride (GaN) transistors, along with related packages and modules. As Renault's key innovation partner, STMicroelectronics will benefit from significant volumes guaranteed for the annual usage of these power modules and transistors from 2026-2030. 
"We are delighted to work with market leader STMicroelectronics to integrate their advanced power electronics and to co-develop technologies to further improve the energy capacity of our electric and hybrid vehicle batteries and their performance on the road and when charging. This partnership secures future supplies of key components which will significantly contribute to reducing wasted energy by 45% and decreasing the cost of the e-powertrain by 30%, helping us fulfil our ambition of making electric vehicles affordable, profitable and popular," said Luca de Meo, Chief Executive Officer, Renault Group. 
"ST is at the forefront of the development of advanced power semiconductors enabling the mobility industry to move to electrified platforms. With higher-efficiency products and solutions based on advanced materials such as Silicon Carbide and Gallium Nitride, we will support Renault Group's strategy for its next generation of electric and hybrid platforms," said Jean-Marc Chery, President and Chief Executive Officer, STMicroelectronics. "ST and Renault Group share a common vision for more sustainable mobility. This partnership will be another step forward in the progressive decarbonization process initiated by the mobility industry and its supply chain." 
Sustainability and sustainable technology are at the heart of both Renault Group's and STMicroelectronics' vision and solutions. For ST, this strategic cooperation is further evidence of how its technologies and products enable more sustainable mobility as well as advanced power and energy management across all type of systems and devices. The transition to more energy-efficient technologies and improved power performance for the operation of full electric and hybrid vehicles will enable Renault Group to continue making concrete improvements to carbon emissions reduction, in line with its objective of achieving carbon neutrality in Europe by 2040 and worldwide by 2050.
A presentation of the Renault tech ecosystem, including this strategic cooperation with STMicroelectronics, will be shared in the Renault eWays online conference which will take place on Wednesday 30th June 2021 at 11:00 am (CET). During the event Luca de Meo and his team will showcase the strategy to position Renault Group at the forefront of electrification making affordable and profitable EVs. Click here to join the event and the Q&amp;A with analysts.

Renault Group and STMicroelectronics Announced Strategic Cooperation on Power Electronics

Credit Suisse analyst Matthew Cabral initiates coverage on Desktop Metal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DM#NYSE">DM</a>) with a Neutral rating and announces Price Target of $14.

Credit Suisse Initiates Coverage On Desktop Metal with Neutral Rating, Announces Price Target of $14

UP Fintech Holding Limited (Nasdaq: <a class="ticker" href="https://www.benzinga.com/stock/tigr#Nasdaq">TIGR</a>) today announced that its Singapore subsidiary, Tiger Brokers (Singapore) Pte. Ltd. or ("TBSPL") has received approval-in-principle to be admitted as a Clearing Member of The Central Depository (Pte) Limited ("CDP"). TBSPL also received approval-in-principle from Singapore Exchange Securities Trading Limited ("SGX") as well as Singapore Exchange Derivatives Trading Limited for admission as a trading member.
The Company expects to use these approvals-in-principle to improve the user experience and services it offers to clients. TBSPL looks forward to developing its partnerships with CDP and SGX and strengthening its presence in the Singapore market.

TIGR

UP Fintech Holding Announced its Singapore Subsidiary, Tiger Brokers, Received Approval-in-Principle Regarding Securities Trading and Clearing in Singapore

Aurinia Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auph#NASDAQ">AUPH</a>) announced today that the Company's licensing partner, Otsuka Pharmaceutical Europe Ltd. (OPEL), filed an initial Marketing Authorization Application (MAA) for voclosporin for the treatment of lupus nephritis (LN) to the European Medicines Agency (EMA). LN is a complication of the autoimmune disease systemic lupus erythematosus (SLE) that seriously impacts the kidneys. In January 2021, the U.S. Food and Drug Administration (FDA) approved voclosporin in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active LN and it is currently available in the U.S. under the brand name LUPKYNIS&#8482;. 
In December 2020, Aurinia entered into a collaboration and licensing agreement with OPEL for the development and commercialization of voclosporin for the treatment of LN in the European Union, Japan, the United Kingdom, Russia, Switzerland, Norway, Belarus, Iceland, Liechtenstein, and Ukraine. Once the MAA is approved, OPEL would be authorized to market voclosporin in the European Union, Norway, Iceland, and Liechtenstein. As part of the agreement, Aurinia received a $50 million U.S. upfront cash payment with the potential to secure up to $50 million U.S. in additional regulatory and reimbursement milestone payments. In addition, Aurinia will receive tiered royalties ranging from 10 to 20 percent, dependent on net and annual sales following commercialization, along with additional milestone payments based on the attainment of certain annual sales by OPEL. Voclosporin will be provided to OPEL under a cost-plus supply agreement. 
"Lupus nephritis is a serious, complex condition that historically has lacked dedicated, approved treatment options," said Peter Greenleaf, President and Chief Executive Officer of Aurinia Pharmaceuticals. "We look forward to continuing to work with Otsuka to expand access to voclosporin and provide patients and physicians access to this new therapy that addresses a significant unmet need in lupus nephritis."

Small Cap

AUPH

Aurinia Pharmaceuticals Announced Licensing Partner Otsuka Filed Initial Marketing Authorization Application for Voclosporin with the European Medicines Agency

RBC Capital analyst Mike Dahl upgrades GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) from Sector Perform to Outperform and raises the price target from $50 to $60.

RBC Capital Upgrades GMS to Outperform, Raises Price Target to $60

Jefferies analyst Philip Ng upgrades Martin Marietta Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) from Hold to Buy and raises the price target from $360 to $424.

Jefferies Upgrades Martin Marietta Materials to Buy, Raises Price Target to $424

&nbsp;
Shares of GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) increased by 12.81% in the past three months. Before we understand the importance of debt, let us look at how much debt GMS has.
<h2>GMS&#39;s Debt</h2>
According to the GMS&#39;s most recent financial statement as reported on June 24, 2021, total debt is at $978.43 million, with $932.41 million in long-term debt and $46.02 million in current debt. Adjusting for $167.01 million in cash-equivalents, the company has a net debt of $811.41 million.
Let&#39;s define some of the terms we used in the paragraph above. Current debt is the portion of a company&#39;s debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents include cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.
Investors look at the debt-ratio to understand how much financial leverage a company has. GMS has $2.48 billion in total assets, therefore making the debt-ratio 0.39. As a rule of thumb, a debt-ratio more than one indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 35% might be higher for one industry and average for another.
<h2>Why Debt Is Important</h2>
Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.
However, due to interest-payment obligations, cash-flow of a company can be impacted. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.
Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. <a href="https://pro.benzinga.com/">Click here to learn more</a>.
&nbsp;
<img alt="A Look Into GMS's Debt" src="https://www.benzinga.com/files/images/story/2021/1624613280_0.png" />
&nbsp;

Intraday Update

GMS: Debt Insights

Jefferies analyst Philip Ng upgrades Vulcan Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) from Hold to Buy and raises the price target from $180 to $207.

Jefferies Upgrades Vulcan Materials to Buy, Raises Price Target to $207

Notwithstanding Tesla Inc&#39;s (NASDAQ:<a class="ticker" href="/stock/TSLA#NASDAQ">TSLA</a>) recent strong fundamental performance, Wall Street analysts have invariably raised concerns regarding its meteoric valuation.

The Tesla Analyst: Bernstein&#39;s Toni Sacconaghi downgraded Tesla from Market Perform to Underperform and maintained the price target at $900.

The Tesla Thesis: Bernstein is bullish on the electric vehicle&nbsp;industry in general and the structural advantage the company may hold.

Sacconaghi said Tesla&#39;s margins could improve materially, premised on favorable mix shift, new local manufacturing facilities, autopilot deferred recognition and EV credits. Additionally, new businesses could confer <a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16129354/teslas-fsd-package-shows-automakers-potential-for-software-revenue">option value</a>.

The company also enjoys the distinction of being a leader in a huge underpenetrated market.

However, Tesla&#39;s &quot;mindboggling&#39; valuation,&quot; which currently measures up to the combined valuation of Toyota Motor Corp (NYSE:<a class="ticker" href="/stock/TM#NYSE">TM</a>) and VOLKSWAGEN AG/ADR (OTC:<a class="ticker" href="/stock/VWAPY#OTC">VWAPY</a>), is unprecedented for a large-cap stock outside of the tech bubble, Sacconaghi said. This is despite Tesla making 500,000 cars compared to the 20 million cars collectively made by Toyota and Volkswagen.

&quot;We struggle to translate our positive views on Tesla as a business into an expected value that is north of ~$900/share,&quot; he wrote in the note. &quot;Tesla now even looks expensive vs. large cap growth tech.&quot;

TSLA Price Action: Tesla shares traded around&nbsp;$1,532.43 at the time of publication.

Related Links:

<a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16615603/several-fundamental-risks-overlooked-as-tesla-approaches-2-000-morgan-stanley">Several Fundamental Risks Overlooked As Tesla Approaches $2,000: Morgan Stanley</a>

<a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16569294/how-teslas-chinese-ev-market-is-worth-400-per-share">How Tesla&#39;s Chinese EV Market Is Worth $400 Per Share</a>

Analyst Color

Downgrades

Why Tesla's 'Mindboggling' Valuation Is Difficult To Sustain Even Under Most Bullish Scenario

Tesla Inc (NASDAQ:<a class="ticker" href="/stock/TSLA#NASDAQ">TSLA</a>) got a price target hike on Wednesday, but the analyst remains bearish on the stock and says too much success is already priced in.

The Tesla Analyst: Morgan Stanley analyst <a href="https://www.tipranks.com/analysts/adam-jonas">Adam Jonas</a> reiterated his Underperform rating for Tesla and raised his price target from $740 to $1,050.

The stock traded around $1,500 at time of publication.

The Tesla Thesis:&nbsp;Jonas said it has become obvious that Tesla will become one of the largest automakers in the world, rivaling the likes of Toyota Motor Corp (NYSE:<a class="ticker" href="/stock/TM#NYSE">TM</a>) or VOLKSWAGEN&nbsp;(OTC:<a class="ticker" href="/stock/VWAPY#OTC">VWAPY</a>) over time. Jonas&rsquo; new target represents a forecast of 3 million vehicle deliveries per year for Tesla by 2030, up from his previous estimates of 2.3 million. Tesla has said it will deliver 500,000 vehicles in 2020, but it delivered just 179,050 in the first half of the year.

In addition to his new forecast of 3 million annual deliveries by 2030, Jonas&rsquo; new Tesla price target assumes Tesla will achieve double the margins and average sales prices of the rest of the auto industry. However, given Tesla&#39;s $277 market cap already far exceeds Toyota, Volkswagen and others, Jonas said the company would need to significantly exceed those targets for him to consider upgrading the stock.

&ldquo;The current share price discounts roughly 5 million units, which implies as much as 10% of industry revenues and roughly 20 to 30% of industry profit,&rdquo; he wrote in the note.

If Tesla exceeds these expectations, Jonas said his bull case price target is $2,500.

However, Jonas said Tesla faces three major risks to its 10-year outlook:

<ul>
	<li>Tesla may be overly dependent on China.</li>
	<li>The market may be underestimating the competition from legacy automakers and tech companies.</li>
	<li>Investors may have an overly optimistic timeline for autonomous opportunities.</li>
</ul>

If any of these risks prove to be real problems for Tesla, Morgan Stanley&rsquo;s bear case price target for the stock is $375.

Benzinga&rsquo;s Take: According to Jonas, Tesla shares are already valued as if the company will be delivering 5 million vehicles per year by 2030 and capturing at least 20% of the global auto industry&rsquo;s profits. Tesla may need to do even better than that baseline if investors want to see significant upside to the stock after its huge recent run.

Related Links:

<a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16811779/the-auto-industry-is-recovering-faster-than-expected-analyst-says">The Auto Industry Is Recovering &#39;Faster Than Expected,&#39; Analyst Says </a>

<a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16772871/is-now-the-time-to-short-teslas-stock">Is Now The Time To Short Tesla&#39;s Stock?</a>

Reiteration

Morgan Stanley Raises Tesla's Price Target, But Remains Bearish

TSLA

VWAPY

Volkswagen foresees upward trend with orders and deliveries up Y/Y in September

Volkswagen Q3 U.S. sales down 7.6% to 86,446 vehicles

Jervois Mining: Moving Up The Value Chain In Preparation For Increasing EV Adoption

Tesla's Model 3 Lost In The World's Most Advanced EV Market In A Peak Month

Tesla's Ego Suffers A Hit And Run From Volkswagen's ID

Volkswagen: Significant Upside From Closing The EV Gap

Volkswagen: Preparing For An All-Electric Future

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
For many investors, 2020 has become synonymous with the success of electric vehicle makers, such as Workhorse (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkhs-stock-quote/">WKHS</a>). Since the start of the year, the shares are up over 500%. Put another way, the proverbial $1,000 invested in the stock in January would now be well over $6,000.
	<div>
		<img src="https://investorplace.com/wp-content/uploads/2020/09/wkhs_1600_b_workhorse-300x169.jpg" alt="Image of a Workhorse (WKHS) logo and drone on the side of a truck." width="300" height="169" /><div>Source: Photo from WorkHorse.com</div>
	</div>
	
Ohio-based EV group Workhorse&nbsp;manufactures electrically powered delivery and utility vehicles. Its focus is on the last-mile delivery sector. These EVs are powered by a modular battery pack system. The <a href="https://workhorse.com/cseries.html" target="_blank">power output</a> is typically between 35 and 70 kWh. Workhouse EVs also have its proprietary telematics vehicle-tracking system, <a href="http://www.workhorse.com/metron.html" target="_blank">Metron</a>.
On Nov. 9, the company released Q3 results. Therefore today, we will discuss the prospects for Workhorse and whether investors should buy the shares now. You may consider investing in the stock if there is short-term profit-taking, and the price declines to $15 or even below.
<h3>Industry Fundamentals Support EVs</h3>
Recent research led by Nele Rietmann of the University of St. Gallen, Switzerland,&nbsp;<a href="https://www.alexandria.unisg.ch/260642/1/2020_Rietmann%20Huegler%20Lieven_Forecasting%20the%20trajectory%20of%20electric%20vehicle%20sales%20and%20theconsequences%20for%20worldwide%20CO2%20emissions.pdf" target="_blank">highlights</a>, &ldquo;overall, 30% of the worldwide passenger vehicle fleet will be EVs in 2032. However, results also display vast differences between countries, which can particularly be attributed to divergences in governmental support.&rdquo;

		<ul><li>
				<a href="https://investorplace.com/2020/11/7-a-rated-stocks-to-buy-that-are-all-weather-winners/">
					7 A-Rated Stocks To Buy That Are All-Weather Winners				</a>
			</li>
				</ul>After January 2021, President-elect Biden is expected to make&nbsp;<a href="https://joebiden.com/clean-energy/" target="_blank">environmental protection</a> one of his top priorities. More &ldquo;electric vehicle charging stations,&rdquo; building &ldquo;zero-emissions public transportation options through flexible federal investments,&rdquo; generating &ldquo;clean, American-made electricity to achieve a carbon pollution-free power sector by 2035,&rdquo; and investing &ldquo;in energy efficiency in buildings&rdquo; were among Biden&rsquo;s campaign promises.
Following the U.S. Presidential election, Herbert Diess, CEO of car manufacturer Volkswagen (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vwapy-stock-quote/">VWAPY</a>) <a href="https://www.autonews.com/executives/vw-ceo-says-biden-victory-would-better-suit-automakers-strategy" target="_blank">commented</a> that a Biden administration would provide tailwinds for global EV sales.
As a result, future years will likely see further electrification of both passenger cars and delivery fleets. Such a development would understandably benefit Workhorse.
On a side note, in addition to its core operations, Workhorse Group has 10% ownership in Lordstown Motors (NASDAQ:<a href="https://investorplace.com/stock-quotes/ride-stock-quote/">RIDE</a>). As a newcomer to the EV industry, <a href="https://investorplace.com/2020/11/ride-stock-is-one-electric-vehicle-name-worth-considering/">RIDE specializes in electric pickup trucks</a>. Earlier in August, publicly listed special purpose acquisition company (SPAC) DiamondPeak and Lordstown Motors released a merger announcement. In October, the reverse-merger finalized.
Therefore, the moves in the price of RIDE stock will also affect the fortunes of Workhorse, which in its Q3 release, <a href="https://ir.workhorse.com/news-events/press-releases/detail/161/workhorse-group-reports-third-quarter-2020-results" target="_blank">said</a>, &ldquo;That stake is estimated at nearly $285 million based on the November 6th closing price.&rdquo;
<h3>How Q3 Results Came for Workhorse</h3>
Quarterly revenue was $565,000. A year ago, it had been $4,000. The company has recently received an order for 500 trucks from Pritchard Auto Company. The deal will be financed by <a href="https://www.hitachicapitalamerica.com/" target="_blank">Hitachi Capital America</a>.
Cost of goods sold (COGS) and operating expenses came at $2.82 million and $7.56 million, respectively. Analysts noted the jump in the interest expense. It was $74.3 million in Q3, compared to $5.9 million in Q3 2019. Management said the increase was primarily due to a change in the fair value of the convertible notes, which required non-cash GAAP adjustments.
CEO Duane Hughes highlighted <a href="https://www.sec.gov/Archives/edgar/data/1425287/000162828020016042/wkhs-20201109ex991earn.htm">various challenges posed by the pandemic</a>. The primary battery supplier to Workhorse has not been able meet targets &ldquo;due to capacity issues and COVID-related slowdowns.&rdquo;
He further commented, &ldquo;Previously, we projected 300-400 vehicles to be produced by the end of 2020, mostly in the fourth quarter. Although we will still manufacture and deliver vehicles in Q4, it will be a substantially lower amount than our previous guidance. We are unable to give a specific estimate.&rdquo;
McKinsey Center for Future Mobility&nbsp;<a href="https://www.mckinsey.com/~/media/McKinsey/Industries/Automotive%20and%20Assembly/Our%20Insights/Expanding%20electric%20vehicle%20adoption%20despite%20early%20growing%20pains/Expanding-electric-vehicle-adoption-despite-early-growing-pains-final.pdf" target="_blank">suggests</a>, &ldquo;Overall, global EV-sales volumes are becoming large enough to create substantial profit pools for well-positioned suppliers and other upstream players.&rdquo;
Yet, Workhouse is not one of those companies. In Q3, net loss hit $84.1 million, compared with a net loss of $11.5 million a year ago. Management blamed the increase in net interest expense for the increase in loss.
Investors were overall pleased with the quarterly results. On Nov. 6, the shares closed at $17.29. But after the release of the numbers, on Nov. 9, the stock finished the day at $18.96. That is an impressive increase of over 9.6%.

<h3>The Bottom Line on WKHS Stock</h3>
Despite the increased revenue, Workhorse is not yet profitable. Its price-to-sales ratio is an eye-popping 7,300x. The group&rsquo;s 2021 production volume target stands at 1,800 vehicles. That number would not justify such a high P/S metric.
Workhorse also has a beta of over 3.1. That is a high metric, warning investors how risky the stock is, especially, in the short-term, compared to the broader market. Therefore, a roller-coaster ride in the future is to be expected.&nbsp;
Are you one of those investors who have been able to ride the stellar increase in the share price? Then you may consider hedging their positions with monthly at-the-money (ATM) covered calls. You could benefit from a further increase in price and have some protection from subsequent profit-taking.
Potential investors may consider any decline toward the $15 level as a better entry point into the shares.
If you are not yet ready to commit capital into Workhorse, you could also buy an exchange-traded fund that holds the shares. Examples include the Amplify Lithium &amp; Battery Technology ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/batt-stock-quote/">BATT</a>), the ARK Autonomous Technology &amp; Robotics&nbsp;ETF&nbsp;(NYSEARCA:<a href="https://investorplace.com/stock-quotes/arkq-stock-quote/">ARKQ</a>), the&nbsp;Invesco WilderHill Clean Energy ETF&nbsp;(NYSEARCA:<a href="https://investorplace.com/stock-quotes/pbw-stock-quote/">PBW</a>), or the SPDR S&amp;P Kensho New Economies Composite ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/komp-stock-quote/">KOMP</a>).
On a final note, in the coming quarters, we may see consolidation in the EV space. Workhorse could easily become a takeover candidate, creating shareholder value.
On the date of publication, Tezcan Gecgil did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Tezcan Gecgil has worked in investment management for over two decades in the U.S. and U.K. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) examination. Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation.
<h3>More From InvestorPlace</h3>
		<ul><li>
				<a href="https://investorplace.com/2020/05/legendary-stock-pickers-controversial-message-about-5g/?cid=MKT464279&amp;eid=MKT469673">
					Why Everyone Is Investing in 5G All WRONG				</a>
			</li>
					<li>
				<a href="https://investorplace.com/2020/02/americas-1-stock-picker-reveals-next-1000-winner-totally-free-of-charge/?cid=MKT462609&amp;eid=MKT465996">
					Top Stock Picker Reveals His Next 1,000% Winner				</a>
			</li>
					<li>
				<a href="https://investorplace.com/2020/06/forever-battery/?cid=MKT450270&amp;eid=MKT473518">
					Radical New Battery Could Dismantle Oil Markets				</a>
			</li>
					<li>
				<a href="https://investorplace.com/2020/03/next-big-thing-5g-opportunity/?cid=MKT446342&amp;eid=MKT457741">
					Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company				</a>
			</li>
					<li>
				<a href="https://investorplace.com/stocks-to-buy-ahead-of-2020-election/">
					Daily Picks: Stocks to Buy Ahead of the Election				</a>
			</li>
				</ul><div>
		<div>
			<div></div>
						<div></div>
					</div>
	</div>The post <a href="https://investorplace.com/2020/11/workhorse-wkhs-stock-back-on-the-road/">Why Workhorse Stock Is Back on the Road to $30</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Workhorse Stock Is Back on the Road to $30

Merger Arbitrage Analysis And Spread Performance - November 15, 2020

QuantumScape: Building The Battery Of The Future

Volkswagen's global sales declined 9% in November

Audi: A Better Version Of Volkswagen

The Economic Dashboard Continues To Flash Some 'Caution' Lights

Tesla Vs. Volkswagen: An EV Showdown

Volkswagen's global sales declined 15.2% in FY2020

Volkswagen: Tesla's First Credible Challenger For EV Domination

GameStop: Short Squeeze Is Over, Take Your Profits While You Can

Ford, Volkswagen EV battery supplier defeated in trade secrets case

Tesla: The Price Of Success And Higher Expectations

Volkswagen to double target for European EV market share

QuantumScape: An Exciting Speculation In Lithium Battery Innovation

Volkswagen Builds A Battery

Volkswagen AG ADR (VWAGY) CEO Herbert Diess on Q4 2020 Results - Earnings Call Transcript

QuantumScape: Nothing More Than A Gambling Stock

Volkswagen shares pull back as trading frenzy draws regulator's attention

Volkswagen: An Electrifying Arbitrage Opportunity

Volkswagen U.S. sales grew 21% in Q1

Ford, VW battery suppliers reach last-minute deal to avoid import ban

Nano One: Another Piece

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>

What&rsquo;s new with IBM stock? IBM (NYSE:<a href="https://investorplace.com/stock-quotes/ibm-stock-quote/">IBM</a>) announced a <a href="https://www.reuters.com/technology/ibm-unveils-2-nanometer-chip-technology-faster-computing-2021-05-06/" target="_blank">milestone</a> in semiconductor manufacturing yesterday. Now, the company is able to produce chips that are just 2 nanometers thick.
<div><img src="https://investorplace.com/wp-content/uploads/2021/05/ibm-building-1600-300x169.jpg" alt="Photo of IBM (IBM) building as seen through the canopy of a tree. IBM logo is in large letters on side of building." width="300" height="169" /><div>Source: shutterstock.com/LCV</div></div>
On top of that, IBM CEO Arvind Krishna recently joined the White House and members of Congress in endorsing the <a href="https://www.ibm.com/policy/endless-frontier-act/?social_post=4748466404&amp;linkId=116795911" target="_blank">Endless Frontier Act</a>. The bill would direct some $100 billion in spending to the National Science Foundation as the U.S. responds to <a href="https://www.cnbc.com/2021/03/01/chinas-spending-on-rd-hits-a-record-378-billion.html#:~:text=China's%20spending%20on%20research%20and%20development%20climbed%2010.3%25%20to%202.44,nation's%20National%20Bureau%20of%20Statistics." target="_blank">competition from China</a> and Russia.
Here&rsquo;s what you should know about IBM stock and the larger scene.

<h3>The Details: IBM Stock and the &lsquo;Tech Trifecta&rsquo;</h3>
Demand for increased chip performance and energy efficiency continues to rise. What&rsquo;s driving it? The &ldquo;tech trifecta&rdquo;: Cloud, AI (Artificial Intelligence), and IoT (Internet of Things). IBM&rsquo;s new 2nm chip technology helps address this growing demand, though it is still several years away from full-scale manufacturing. Ultra-low nanometer chips consume less power, take up less space and reduce cost.
<ul><li>
				<a href="https://investorplace.com/2021/05/7-stocks-to-buy-right-now-with-all-eyes-on-crypto/"> 
					7 Stocks to Buy Right Now With All Eyes on Crypto				</a>
			</li>
</ul><ul><li>Better performance and energy efficiency. IBM&rsquo;s 2-nanometer chip improves performance by 45% over today&rsquo;s 7-nanometer designs and uses 75% less energy.</li>
<li>Push for more U.S. chip manufacturing amidst a global chip shortage. The mandate: boost American chip manufacturing to protect national security and economic competitiveness. A global chip shortage highlights the importance of the U.S. having its own domestic capacity. This way it can rely less on foundries in China and Taiwan.
<ul><li>Mainstream chip-makers Intel (NASDAQ:<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>) and Taiwan Semiconductor (NYSE:<a href="https://investorplace.com/stock-quotes/tsm-stock-quote/">TSM</a>) have announced <a href="https://www.wsj.com/articles/taiwan-company-to-build-advanced-semiconductor-factory-in-arizona-11589481659" target="_blank">plans to build ultra-low nanometer chip plants</a> in the coming years.</li>
<li>Intel also recently <a href="https://www.cnbc.com/2021/03/23/intel-is-spending-20-billion-to-build-two-new-chip-plants-in-arizona.html" target="_blank">recommitted to continuing in-house chipmaking</a> and vowed to invest $20 billion to build two new chipmaking plants in Arizona.</li>
<li>IBM&rsquo;s Krishna called for fully funding the National Semiconductor Technology Center authorized by Congress last year. Krishna suggested placing it in Albany, New York, where IBM has a research center.</li>
</ul></li>
</ul><ul><li>Covid-19 teaches us it&rsquo;s time to focus on American science. IBM endorsed the <a href="https://www.young.senate.gov/newsroom/press-releases/young-schumer-unveil-endless-frontier-act-to-bolster-us-tech-leadership-and-combat-china" target="_blank">Endless Frontier Act</a>, recently re-introduced by hometown denizen and Senate Majority Leader Chuck Schumer (D-NY) and Todd Young (R-IN). The goal?
<ul><li>Reverse the serious disinvestment in science and research that has undermined U.S. healthcare and national security.</li>
<li>Invest in innovative research by mobilizing the country&rsquo;s scientific talent in universities, research labs and the private sector.</li>
<li>This is because federal funding for basic research has <a href="https://www.sciencemag.org/news/2017/03/data-check-us-government-share-basic-research-funding-falls-below-50" target="_blank">steadily declined</a> since the 1960s. It now comprises less than 50% of all funding. This decline is in stark contrast to countries like China and Russia, which are steadily increasing government funding.</li>
</ul></li>
</ul><h3>IBM Stock News: How to Get an Edge</h3>
<ul><li>Buy semi equipment manufacturers on the dip. Coming out of a two-year downturn, the industry under-invested in back-end equipment. Now the semiconductor cycle is about to heat up. Companies that specialize in back-end semiconductor and electronics assembly equipment are going to be the first to ride a massive demand wave. New equipment is needed to manufacture ultra-low nanometer chips. This includes extreme ultraviolet (EUV) lithography and new deposition, etch, inspection and metrology technologies.
<ul><li>This is a perfect time to buy Kulicke &amp; Soffa (NASDAQ:<a href="https://investorplace.com/stock-quotes/klic-stock-quote/">KLIC</a>), which is down over 10% this week as investors &ldquo;sell the news.&rdquo; Looking closer, KLIC handily <a href="https://www.cnbc.com/quotes/KLIC?tab=earnings" target="_blank">beat earnings</a>, guided higher and signaled strong demand.</li>
<li>Other names poised to benefit are Advanced Energy Industries (NASDAQ:<a href="https://investorplace.com/stock-quotes/aeis-stock-quote/">AEIS</a>), ASML&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/asml-stock-quote/">ASML</a>), Ichor&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ichr-stock-quote/">ICHR</a>), Nova Measuring Instruments (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvmi-stock-quote/">NVMI</a>) and Onto Innovation (NYSE:<a href="https://investorplace.com/stock-quotes/onto-stock-quote/">ONTO</a>).</li>
</ul></li>
<li>Get an early start and invest in AI. New processors from IBM and others will be an important ingredient in <a href="https://analyticsindiamag.com/the-different-types-of-hardware-ai-accelerators/" target="_blank">AI accelerators</a>, specialized hardware designed to speed up AI applications. These include speech and natural language processing and speech-to-text. Look for broader deployment of AI in unconventional areas like financial services, where it can be used for fraud detection. The best stocks to buy are those with proprietary tech in machine learning and neural networks.
<ul><li>My favorite names in this space include Nvidia&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>), Twilio (NYSE:<a href="https://investorplace.com/stock-quotes/twlo-stock-quote/">TWLO</a>), Microsoft (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/">MSFT</a>), Docusign (NASDAQ:<a href="https://investorplace.com/stock-quotes/docu-stock-quote/">DOCU</a>) and Dropbox (NASDAQ:<a href="https://investorplace.com/stock-quotes/dbx-stock-quote/">DBX</a>).</li>
</ul></li>
<li>Wait before jumping back into auto stocks. While having bounced from pandemic lows, the chip shortage has caused a recent pullback in auto stocks, with Ford (NYSE:<a href="https://investorplace.com/stock-quotes/f-stock-quote/">F</a>), General Motors (NYSE:<a href="https://investorplace.com/stock-quotes/gm-stock-quote/">GM</a>) and others having all cited problems. However, not everyone felt the impact equally this quarter.
<ul><li>Volkswagen (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vwapy-stock-quote/">VWAPY</a>) stock dropped despite solid earnings and strong electric vehicle (EV) sales, warning of the impact of the chip shortage.</li>
<li>Meanwhile, Volvo (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vlvly-stock-quote/">VLVLY</a>) breezed through earnings, reporting strong results despite a <a href="https://www.reuters.com/article/us-volvo-results/ab-volvo-rides-demand-recovery-but-chip-woes-loom-idUSKBN2C90JS" target="_blank">sizeable production decline</a> in the first quarter. The shortage appears to have had limited impact for now, but it will likely cause more disruption in Q2 and potentially Q3. That means it may still be too soon to jump into these stocks.</li>
</ul></li>
</ul>
<h3>The Bottom Line</h3>
IBM stock represents an innovative push toward efficient, ultra-low nanometer chips. However, this recent development also signals a bigger push into the technology trifecta of AI, IoT and Cloud.
Growth investors: don&rsquo;t miss out on these multi-year investment cycles. Microsoft remains my favorite large-cap AI play, but there are plenty of small- and mid-cap ideas across all three areas. This is also a great time to buy semi equipment manufacturers on the recent selloff.
On the date of publication, Joanna Makris did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Joanna Makris is a Market Analyst at&nbsp;<a href="http://investorplace.com/">InvestorPlace.com</a>. A strategic thinker and fundamental public equity investor, Joanna leverages over 20 years of experience on Wall Street covering various segments of the Technology, Media, and Telecom sectors at several global investment banks, including Mizuho Securities and Canaccord Genuity.
<h3>More From InvestorPlace</h3>
<ul><li>
				<a href="https://investorplace.com/2020/05/legendary-stock-pickers-controversial-message-about-5g/?cid=MKT464279&amp;eid=MKT469673"> 
					Why Everyone Is Investing in 5G All WRONG				</a>
			</li>
<li>
				<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT513141"> 
					It doesn&rsquo;t matter if you have $500 in savings or $5 million. Do this now.				</a>
			</li>
<li>
				<a href="https://investorplace.com/2020/02/americas-1-stock-picker-reveals-next-1000-winner-totally-free-of-charge/?cid=MKT462609&amp;eid=MKT465996"> 
					Top Stock Picker Reveals His Next Potential 500% Winner				</a>
			</li>
<li>
				<a href="https://investorplace.com/2021/02/silicon-valley-whiz-kid-reveals-top-tech-stock/?cid=MKT516215&amp;eid=MKT524303"> 
					Stock Prodigy Who Found NIO at $2&hellip; Says Buy THIS Now				</a>
			</li>
</ul><div>
<div>
<div></div>
<div></div>
</div>
</div>

The post <a href="https://investorplace.com/2021/05/new-ibm-chip-just-got-boost-from-biden-bill/">The New IBM Chip Just Got a Boost from Biden Bill</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The New IBM Chip Just Got a Boost from Biden Bill

Fisker: Too Late To Join The EV Party

Volkswagen: Buy This Future EV Leader Before It's Too Late

Volkswagen to get $351M in diesel fraud settlements from former execs

QuantumScape Is Truly A Speculative Bet For The Future

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>

Tesla (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) is ready for its final push. TSLA stock is a double-edged sword. On one hand, you have the best EV maker in the world with promising upside in solar and energy storage. But you also have a ton of new competition entering the electric vehicle space in 2022. And the solar energy and energy storage businesses aren&rsquo;t exactly booming.
<div><img src="https://investorplace.com/wp-content/uploads/2019/07/TSLA_google-300x169.jpg" alt="Tesla (TSLA) logo on city building at night" width="300" height="169" /><div>Source: Vitaliy Karimov / Shutterstock.com</div></div>
The current situation is a cocktail for near-term alpha and long-term beta in the stock.
The near-term alpha is predicated on the fact that Tesla is killing it in China currently. Its Model 3 and Model Y are excelling. The latter of which was <a href="https://seekingalpha.com/news/3709230-major-automakers-turn-the-corner-on-global-chip-shortage">the best selling BEV in China in the second quarter</a> according to UBS.
These strong growth trends will help Tesla report solid second- and third-quarter numbers. As a result, TSLA stock should soar back to all-time highs.
However, we think that&rsquo;s Tesla&rsquo;s last hurrah.
<h3>Buy TSLA Stock Today, Sell the Future Rally</h3>
New competition is coming. All the legacy auto makers &mdash; like Ford (NYSE:<a href="https://investorplace.com/stock-quotes/f-stock-quote/">F</a>), General Motors (NYSE:<a href="https://investorplace.com/stock-quotes/gm-stock-quote/">GM</a>), Volkswagen (OTC:<a href="https://investorplace.com/stock-quotes/vwapy-stock-quote/">VWAPY</a>) &mdash; are transitioning to electric.
At the same time, many new entrants are launching EVs in 2022 and 2023 such as Lucid Motors (NYSE:<a href="https://investorplace.com/stock-quotes/cciv-stock-quote/">CCIV</a>), Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) and Canoo (NASDAQ:<a href="https://investorplace.com/stock-quotes/goev-stock-quote/">GOEV</a>). Some of these companies offer <a href="https://investorplace.com/hypergrowthinvesting/2021/06/lucid-motors-stock-no-1-stock-to-buy-beat-tesla/">EVs that are superior to Tesla&rsquo;s</a>.
China&rsquo;s big players, like Nio (NYSE:<a href="https://investorplace.com/stock-quotes/nio-stock-quote/">NIO</a>) and Xpeng (NYSE:<a href="https://investorplace.com/stock-quotes/xpev-stock-quote/">XPEV</a>), are starting with a big push in Europe but will expand and reach a global audience soon enough.
Competition is going to heat up a lot in the coming years.
While Tesla may still end up making the best EVs in the world, we think it&rsquo;s silly to assume it won&rsquo;t lose some market share to this wave of competition.
It&rsquo;s going to happen. It&rsquo;s inevitable.
And unfortunately, Tesla isn&rsquo;t priced for market share erosion.
The one thing that could save TSLA in the event of market share erosion is rapid expansion of their solar and energy storage business.
But Tesla leaves us feeling unimpressed by their (lack of) progress in that space. For example, Bloomberg just reported that <a href="https://www.bloomberg.com/news/articles/2021-06-23/tesla-s-solar-roof-rollout-is-a-bust-and-a-fixation-for-elon-musk?sref=0N1JmzAH">its solar business is actually underperforming</a> internal expectations by a wide margin.
All in all, we think TSLA stock is due for a near-term surge but long-term struggles.

Which is exactly why I&rsquo;ve been considering going all-in a new EV stock. One that is primed for early-Tesla-like growth over the months and years to come.
In fact, I have a number of EV stocks in my <a href="https://orders.investorplace.com/?cid=MKT516215&amp;eid=MKT554159&amp;encryptedSnaid=&amp;snaid=&amp;step=start">Innovation Investor</a> portfolio, each of which represents the cream-of-the-crop in disruptive technological innovation. These companies all feature second-to-none management teams and massive long-term potential.
These Next-Gen Mobility stocks include a secret startup that&rsquo;s spearheading the self-driving revolution, a company I consider my EV &ldquo;sleeper&rdquo; stock of the decade, and my No. 1 stock pick to not just rival Tesla, but to completely dominate it.
To see this lineup of innovative next-generation EV stocks, <a href="https://orders.investorplace.com/?cid=MKT516215&amp;eid=MKT554159&amp;encryptedSnaid=&amp;snaid=&amp;step=start">become a subscriber of Innovation Investor today.</a>
On the date of publication, Luke Lango did not have (either directly or indirectly) any positions in the securities mentioned in this article.
By uncovering early investments in hypergrowth industries, Luke Lango puts you on the ground-floor of world-changing megatrends. It&rsquo;s the theme of his premiere technology-focused service, <a href="https://orders.investorplace.com/?cid=MKT516215&amp;eid=MKT554159&amp;encryptedSnaid=&amp;snaid=&amp;step=start">Innovation Investor</a>. To see Luke&rsquo;s entire lineup of innovative cutting-edge stocks, <a href="https://orders.investorplace.com/?cid=MKT516215&amp;eid=MKT554159&amp;encryptedSnaid=&amp;snaid=&amp;step=start">become a subscriber of Innovation Investor today</a>.	
<div>
<div>
<div></div>
<div></div>
</div>
</div>

The post <a href="https://investorplace.com/hypergrowthinvesting/2021/06/buy-tsla-stock-now-but-be-ready-to-sell-when-they-lose-their-edge/">Buy Tesla Stock Now, But Be Ready to Sell</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Buy Tesla Stock Now, But Be Ready to Sell

AAPL

AEIS

ARKQ

ASML

AUDVF

BATT

DOCU

GOEV

ICHR

INTC

KLIC

KOMP

LGCLF

MSFT

NVDA

NVMI

ONTO

RIDE

RNLSY

SAPLF

STLA

TWLO

VLKAF

VLKPF

VLVLY

VWAGY

WKHS

XPEV

MCLEAN, Va., Oct. 12, 2020 /PRNewswire/ -- Appian (NASDAQ:<a class="ticker" href="/stock/APPN#NASDAQ">APPN</a>) today announced that Volkswagen Group of America, Inc. is using Appian&#39;s <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=2944650-1&amp;h=3153581837&amp;u=https%3A%2F%2Fwww.appian.com%2Fworkforce-safety%2F%3Futm_source%3Dreferral%26utm_medium%3Dpress-release%26utm_campaign%3Dworkforce-safety&amp;a=Workforce+Safety+solution" rel="nofollow">Workforce Safety solution</a> to automate the process of helping manage the safe and healthy return of the majority of its U.S. workforce to the workplace in phases, and in accordance with local health conditions. The solution, built on the Appian <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=2944650-1&amp;h=768007999&amp;u=https%3A%2F%2Fwww.appian.com%2Fplatform%2F%3Futm_source%3Dreferral%26utm_medium%3Dpress-release%26utm_campaign%3Dworkforce-safety&amp;a=Low-code+Automation+Platform" rel="nofollow">Low-code Automation Platform</a>, enables Volkswagen to manage the complexities of the workplace return, including prioritizing workforce health and workplace safety.
Volkswagen Group of America is the North American operational headquarters and a subsidiary of Volkswagen AG (FWB: VOW), one of the world&#39;s leading automobile manufacturers and the largest carmaker in Europe. The company, which includes the Volkswagen, Audi, Lamborghini, Bugatti, and Ducati brands, as well as Volkswagen Credit, has approximately 8,000 employees in the United States and sells its vehicles through a 1,000-strong dealer network.
Volkswagen needed a comprehensive mobile solution that could be up-and-running quickly, and that was easily configurable. The Workforce Safety solution, hosted in Appian&#39;s HIPAA-compliant and HiTRUST-certified cloud, provides Volkswagen a fully integrated solution with a central command center to monitor the health and work status of its employees across all locations in real-time. The solution&#39;s Mobile Pass feature uses fast, easy, and self-reported employee health screening to automatically and intelligently generate &#34;safe to return&#34; designations that are displayed on an employee&#39;s mobile device. Complete case management capabilities enable contact tracing and fast resolution of exceptions and appeals.
For more information on the Appian Workforce Safety solution, visit <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=2944650-1&amp;h=249369678&amp;u=https%3A%2F%2Fwww.appian.com%2Fworkforce-safety%2F%3Futm_source%3Dreferral%26utm_medium%3Dpress-release%26utm_campaign%3Dworkforce-safety&amp;a=https%3A%2F%2Fwww.appian.com%2Fworkforce-safety%2F" rel="nofollow">https://www.appian.com/workforce-safety/</a>.
About Appian Appian provides a low-code automation platform that accelerates the creation of high-impact business applications. Many of the world&#39;s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. For more information, visit<a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=2944650-1&amp;h=1194696158&amp;u=http%3A%2F%2Fwww.appian.com%2F%3Futm_source%3Dreferral%26utm_medium%3Dpress-release%26utm_campaign%3Dworkforce-safety&amp;a=%C2%A0" rel="nofollow"> </a><a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=2944650-1&amp;h=965547413&amp;u=http%3A%2F%2Fwww.appian.com%2F%3Futm_source%3Dreferral%26utm_medium%3Dpress-release%26utm_campaign%3Dworkforce-safety&amp;a=www.appian.com" rel="nofollow">www.appian.com</a>.
About Volkswagen Group of America, Inc. Volkswagen Group of America, Inc. (VWGoA) is a wholly owned subsidiary of Volkswagen AG, one of the world&#39;s leading automobile manufacturers and the largest carmaker in Europe. VWGoA operates a manufacturing plant in Chattanooga, Tennessee and houses the U.S. operations of a worldwide family of distinguished and exciting brands including Audi, Bentley, Bugatti, Lamborghini and Volkswagen, as well as VW Credit, Inc. Founded in 1955, the company&#39;s headquarters are in Herndon, Va. The company has 8,000 employees in the United States and sells its vehicles through a network of nearly 1,000 dealers.
<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=PH53242&amp;sd=2020-10-12"></img> View original content:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="http://www.prnewswire.com/news-releases/volkswagen-group-of-america-deploys-appian-workforce-safety-solution-to-support-the-phased-return-of-its-workforce-during-covid-19-301149160.html">http://www.prnewswire.com/news-releases/volkswagen-group-of-america-deploys-appian-workforce-safety-solution-to-support-the-phased-return-of-its-workforce-during-covid-19-301149160.html</a>
SOURCE Appian

Press Releases

Volkswagen Group of America Deploys Appian Workforce Safety Solution to Support the Phased Return of its Workforce during COVID-19

WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Volkswagen AG (OTC:<a class="ticker" href="/stock/VWAGY#OTC">VWAGY</a>, VWAPY, VLKAF, VLKPF))) resulting from allegations that Volkswagen AG may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Volkswagen AG securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-register-2072.html&amp;esheet=52405844&amp;newsitemid=20210401005954&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-register-2072.html&amp;index=1&amp;md5=50c9e3158418c7833add75c4ef9df7d4" shape="rect">http://www.rosenlegal.com/cases-register-2072.html</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:pkim@rosenlegal.com" shape="rect">pkim@rosenlegal.com</a> or <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:cases@rosenlegal.com" shape="rect">cases@rosenlegal.com</a> for information on the class action.

WHAT IS THIS ABOUT: On March 29, 2021, CNBC published an article entitled "VW accidentally leaks new name for its U.S. operations: Voltswagen" stating that "Volkswagen is expected to change the name of its operations in the U.S. to ‘Voltswagen of America,' emphasizing the German automaker's electric vehicle efforts" and that "[a] now unpublished press release called the change a ‘public declaration of the company's future-forward investment in e-mobility.'"

Then on March 30, 2021, the Wall Street Journal published an article entitled "No, Volkswagen Isn't Rebranding Itself Voltswagen" which stated "[t]he name change stunt comes as the company is eager to get U.S. consumers jazzed about the ID. 4, which went on sale in U.S. showrooms this month." The article also stated that "problem for VW is that everyone took it seriously, creating confusion about the company's intentions and moving the shares[.]" Due to the earlier news, the article stated "[i]n the U.S., the company's American depositary receipts rose as much as 12% Tuesday before sliding near the close after the company confirmed the name change was a joke, closing up 9%."

On this news, Volkswagen's American depositary receipt ("ADR") price fell $2.17 per ADR, or 5%, over the next two trading days to close at $35.58 per ADR on April 1, 2021, damaging investors.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;esheet=52405844&amp;newsitemid=20210401005954&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;index=2&amp;md5=e9044d3d81088d8ff3b208f04804ad0e" shape="rect">https://www.linkedin.com/company/the-rosen-law-firm</a>, on Twitter: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;esheet=52405844&amp;newsitemid=20210401005954&amp;lan=en-US&amp;anchor=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;index=3&amp;md5=f54343c531e54edff9997a69ef73821d" shape="rect">https://twitter.com/rosen_firm</a> or on Facebook: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&amp;esheet=52405844&amp;newsitemid=20210401005954&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&amp;index=4&amp;md5=d628c6adf15aa19628d2a49352806618" shape="rect">https://www.facebook.com/rosenlawfirm/</a>.

Attorney Advertising. Prior results do not guarantee a similar outcome.
<img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20210401005954r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20210401005954/en/" rel="nofollow">https://www.businesswire.com/news/home/20210401005954/en/</a>

ROSEN, A TOP RANKED LAW FIRM, Encourages Volkswagen AG Investors to Inquire About Class Action Investigation – VWAGY, VWAPY, VLKAF, VLKPF

NEW YORK, May 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Volkswagen Aktiengesellschaft (&#34;Volkswagen&#34; or the &#34;Company&#34;) (OTCMKTS: VLKAY; VLKPY).  Such investors are advised to contact Robert S. Willoughby at <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:rswilloughby@pomlaw.com" rel="nofollow">rswilloughby@pomlaw.com</a> or 888-476-6529, ext. 7980.

 <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.html" target="_blank" rel="nofollow">
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg" title="Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)" alt="Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)"></img>
 </a>
 

 </div>
The investigation concerns whether Volkswagen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  
<a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3159097-6&amp;h=3048395744&amp;u=https%3A%2F%2Fpomlaw.com%2Flearn-more-form%3Fcompany%3Dvlkay&amp;a=%5BClick+here+for+information+about+joining+the+class+action%5D" rel="nofollow">[Click here for information about joining the class action]</a>
On March 30, the Wall Street Journal published a &#34;WSJ News Exclusive&#34; entitled &#34;No, Volkswagen Isn&#39;t Rebranding Itself Voltswagen: German car maker says announcement by its U.S. operation was supposed to be an April Fools&#39; gag[.]&#34;  The Wall Street Journal article reported, in pertinent part, that &#34;Volkswagen AG&#39;s U.S. subsidiary said Tuesday the company would rebrand itself as Voltswagen of America to promote its electric car strategy, but a spokesman for the parent company in Germany later said the move was a joke.&#34;  
On March 31, 2021, further reports regarding how Volkswagen, Volkswagen of America, and its spokespeople purposefully misled to reporters were published.  For example, ABC News published an article entitled &#34;An unwelcome prank: Volkswagen purposely hoodwinks reporters: Journalists are wary of looking out for pranksters around April Fool&#39;s Day, but this time it came from a multi-billion dollar corporation[.]&#34;  
On this news, Volkswagen&#39;s American Depositary Receipt (&#34;ADR&#34;) price fell $2.14 per ADR, or over 5%, over the next two full trading days, to close at $35.58 per ADR on April 1, 2021, damaging investors.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3159097-6&amp;h=3505905814&amp;u=http%3A%2F%2Fwww.pomerantzlaw.com%2F&amp;a=www.pomerantzlaw.com" rel="nofollow">www.pomerantzlaw.com</a>
CONTACT: Robert S. Willoughby Pomerantz LLP <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:rswilloughby@pomlaw.com" rel="nofollow">rswilloughby@pomlaw.com</a>

<div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
</div>
<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=MN73322&amp;sd=2021-05-11"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-volkswagen-aktiengesellschaft--vlkay-vlkpy-301288199.html">http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-volkswagen-aktiengesellschaft--vlkay-vlkpy-301288199.html</a>
SOURCE Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Volkswagen Aktiengesellschaft - VLKAY; VLKPY

NEW YORK, May 19, 2021 /PRNewswire/ -- 

 <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.html" target="_blank" rel="nofollow">
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg" title="Rosen Law Firm, P.A. Logo" alt="Rosen Law Firm, P.A. Logo"></img>
 </a>
 

 </div>
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) between March 29, 2021 and March 30, 2021, inclusive (the &#34;Class Period&#34;), of the important June 29, 2021 lead plaintiff deadline in the securities class action commenced by the firm.
SO WHAT: If you purchased Volkswagen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Volkswagen class action, go to <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3170092-1&amp;h=1516445292&amp;u=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-register-2072.html&amp;a=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-register-2072.html" rel="nofollow">http://www.rosenlegal.com/cases-register-2072.html</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:pkim@rosenlegal.com" rel="nofollow">pkim@rosenlegal.com</a> or <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:cases@rosenlegal.com" rel="nofollow">cases@rosenlegal.com</a> for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 29, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs&#39; Bar. Many of the firm&#39;s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuits, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Voltswagen&#34; was never going to be used by the Volkswagen, Volkswagen Group of America, Inc. (&#34;VWoA&#34;), or on any relevant vehicle; (2) Volkswagen, VWoA, and their spokespeople purposefully misled reporters regarding the now-purported &#34;joke&#34; and/or &#34;promotion&#34;; and (3) as a result, defendants&#39; public statements and statements to journalists were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Volkswagen class action, go to <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3170092-1&amp;h=1516445292&amp;u=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-register-2072.html&amp;a=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-register-2072.html" rel="nofollow">http://www.rosenlegal.com/cases-register-2072.html</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:pkim@rosenlegal.com" rel="nofollow">pkim@rosenlegal.com</a> or <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:cases@rosenlegal.com" rel="nofollow">cases@rosenlegal.com</a> for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor&#39;s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3170092-1&amp;h=2790944363&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm" rel="nofollow">https://www.linkedin.com/company/the-rosen-law-firm</a>, on Twitter: <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3170092-1&amp;h=2621318207&amp;u=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;a=https%3A%2F%2Ftwitter.com%2Frosen_firm" rel="nofollow">https://twitter.com/rosen_firm</a> or on Facebook: <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3170092-1&amp;h=1812147474&amp;u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&amp;a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F" rel="nofollow">https://www.facebook.com/rosenlawfirm/</a>.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:lrosen@rosenlegal.com" rel="nofollow">lrosen@rosenlegal.com</a> <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:pkim@rosenlegal.com" rel="nofollow">pkim@rosenlegal.com</a> <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:cases@rosenlegal.com" rel="nofollow">cases@rosenlegal.com</a> <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3170092-1&amp;h=4057613299&amp;u=http%3A%2F%2Fwww.rosenlegal.com%2F&amp;a=www.rosenlegal.com" rel="nofollow">www.rosenlegal.com</a>

<div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
</div>
<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://c212.net/c/img/favicon.png?sn=DC84357&amp;sd=2021-05-19"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="http://www.prnewswire.com/news-releases/vwagy-investor-notice-rosen-trusted-investor-counsel-encourages-volkswagen-ag-investors-to-secure-counsel-before-important-deadline-in-first-filed-securities-class-action-commenced-by-the-firm--vwagy-301295465.html">http://www.prnewswire.com/news-releases/vwagy-investor-notice-rosen-trusted-investor-counsel-encourages-volkswagen-ag-investors-to-secure-counsel-before-important-deadline-in-first-filed-securities-class-action-commenced-by-the-firm--vwagy-301295465.html</a>
SOURCE Rosen Law Firm, P.A.

VWAGY INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Volkswagen AG Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm - VWAGY

APPN

Recent Quotes

Related Companies

Volkswagen Frequently Asked Questions

How do I buy Volkswagen (VWAPY) stock?

Who are Volkswagen's (VWAPY) competitors?

What is the target price for Volkswagen (VWAPY) stock?

Current Stock Price for Volkswagen (VWAPY)?

Does Volkswagen (VWAPY) pay a dividend?

When is Volkswagen (OTC:VWAPY) reporting earnings?

Is Volkswagen (VWAPY) going to split?

What sector and industry does Volkswagen (VWAPY) operate in?